sudden
emerg
sever
acut
respiratori
syndrom
coronaviru
end
chines
provinc
hubei
subsequ
pandem
spread
highlight
import
understand
full
molecular
detail
coronaviru
infect
pathogenesi
compar
varieti
replic
featur
sarscov
analys
cytopatholog
caus
two
close
relat
virus
commonli
use
vero
cell
line
compar
sarscov
gener
higher
level
intracellular
viral
rna
strikingli
less
infecti
viral
progeni
recov
cultur
medium
immunofluoresc
microscopi
similar
occur
within
compar
time
frame
infect
furthermor
determin
sensit
two
virus
three
establish
inhibitor
coronaviru
replic
remdesivir
alisporivir
chloroquin
similar
infect
substanti
sensit
pretreat
cell
pegyl
interferon
alpha
import
differ
two
virus
fact
upon
passag
vero
cell
appar
strong
select
pressur
acquir
adapt
mutat
spike
protein
gene
mutat
chang
delet
put
furinlik
cleavag
site
region
connect
domain
result
promin
phenotyp
chang
plaqu
assay
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
introduct
regrett
taken
serious
enough
invest
extens
prophylact
therapeut
solut
could
contribut
rapidli
contain
outbreak
current
magnitud
compar
rna
virus
cov
possess
unusu
larg
positivesens
rna
genom
size
rang
kilobas
cov
genom
singlestrand
twothird
encod
larg
partial
overlap
replicas
polyprotein
amino
acid
long
respect
latter
ctermin
extend
version
former
result
ribosom
frameshift
replicas
polyprotein
process
cleavag
product
structur
protein
nsp
two
intern
proteas
papainlik
proteas
pl
pro
main
proteas
pro
specif
transmembran
nsp
cooper
transform
intracellular
membran
viral
replic
organel
ro
serv
organ
execut
cov
rna
synthesi
entail
genom
replic
synthesi
extens
nest
set
subgenom
sg
mrna
latter
use
express
gene
present
third
genom
encod
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
set
smaller
nsp
mainli
appear
serv
cofactorsmodul
newli
emerg
rapidli
identifi
cov
rel
close
infect
model
mani
laboratori
includ
set
establish
basic
featur
replic
vero
cell
use
throughout
studi
isol
provid
laboratori
worldwid
promot
rapid
character
critic
time
lockdown
prevent
measur
avoid
collaps
public
health
system
report
describ
compar
studi
basic
replic
featur
sarscov
vero
cell
includ
growth
kinet
viru
titr
plaqu
phenotyp
analysi
intracellular
viral
rna
protein
synthesi
addit
analys
infect
cell
light
electron
microscopi
demonstr
crossreact
avail
sarscovspecif
antisera
recognis
differ
viral
protein
counterpart
final
establish
condit
mediumthroughput
assay
evalu
basic
antivir
activ
assess
impact
known
cov
inhibitor
replic
addit
mani
anticip
similar
result
also
establish
remark
differ
two
virus
warrant
investig
one
rapid
evolut
viru
passag
vero
cell
specif
region
protein
contain
socal
furinlik
cleavag
maintain
eagl
minim
essenti
medium
emem
lonza
fc
glutamin
paa
antibiot
sigma
viral
titr
determin
plaqu
assay
vero
cell
describ
previous
plaqu
pick
plaqu
assay
perform
use
stock
use
overlay
contain
agaros
instead
avicel
fmc
biopolym
follow
neutral
red
stain
small
larg
plaqu
pick
use
inocul
dish
vero
cell
contain
ml
fc
medium
yield
viru
h
cultur
supernat
use
infect
next
dish
cell
step
repeat
one
time
obtain
viru
work
live
sarscov
perform
biosafeti
laboratori
level
facil
leiden
univers
medic
center
netherland
leiden
netherland
includ
appropri
qualiti
control
step
procedur
sequenc
perform
use
novaseq
sequenc
system
illumina
subsequ
sequenc
read
screen
presenc
human
mous
e
coli
embl
phix
refseq
common
vector
sequenc
univec
prior
align
read
trim
remov
adapt
sequenc
filter
sequenc
qualiti
remain
read
map
genbank
refer
sequenc
data
analysi
perform
use
bowti
raw
ng
data
set
viru
sampl
analys
studi
deposit
ncbi
bioproject
avail
follow
link
read
includ
data
file
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
studi
evolutionadapt
protein
gene
perform
indepth
analysi
read
cover
region
protein
gene
done
stock
four
viru
sampl
plaqu
pick
experi
shown
fig
first
read
span
nt
sarscov
genom
select
next
read
constitut
less
total
number
select
read
exclud
analysi
remain
number
read
stock
read
translat
protein
open
read
frame
result
amino
acid
sequenc
align
group
basi
contain
mutationsdelet
region
rank
frequenc
occurr
fig
sarscovspecif
rabbit
mous
antiseraantibodi
use
studi
list
tabl
antisera
describ
previous
see
refer
tabl
except
three
rabbit
antisera
recogn
sarscov
nsp
rais
use
fulllength
bacteri
express
product
synthet
peptid
aa
sarscov
use
immun
new
zealand
white
rabbit
describ
previous
crossreact
antisera
target
evalu
microscop
immunofluoresc
assay
ifa
antisera
n
protein
also
western
blot
analysi
doublestrand
rna
detect
use
mous
monoclon
antibodi
scicon
cell
grown
glass
coverslip
infect
describ
h
pi
cell
fix
overnight
use
paraformaldehyd
pb
ph
cell
wash
pb
contain
mm
glycin
permeabil
triton
pb
cell
incub
antisera
dilut
pb
contain
fc
secondari
antibodi
use
goat
antirabbit
igg
antibodi
invitrogen
donkey
antirabbit
igg
antibodi
jackson
immunoresearch
laboratori
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
goat
antimous
igg
antibodi
invitrogen
nuclei
stain
hoechst
thermofisch
sampl
embed
use
prolong
gold
life
technolog
analys
leica
fluoresc
microscop
use
lasx
softwar
isol
receiv
stock
deriv
two
consecut
passag
verohslam
cell
viru
propag
two
time
low
moi
vero
cell
caus
sever
cytopath
effect
cpe
also
attempt
propag
cell
use
amount
viru
tenfold
larger
inoculum
observ
cytopatholog
h
data
shown
h
pi
immunofluoresc
microscopi
see
reveal
infect
small
percentag
cell
without
clear
spread
cell
occur
next
h
therefor
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
conclud
infect
cell
lead
product
infect
deem
cell
line
unsuit
studi
infect
titr
stock
grown
vero
cell
analys
plaqu
assay
notic
mix
plaqu
phenotyp
ratio
small
versu
larg
plaqu
data
shown
viru
titr
x
pfuml
calcul
verifi
ident
genom
sequenc
viru
stock
isol
genom
rna
cultur
supernat
appli
nextgener
sequenc
ng
see
method
detail
result
consensu
sequenc
found
ident
sequenc
previous
deposit
genbank
access
number
one
except
see
compar
genbank
refer
sequenc
field
isol
isol
exhibit
sequenc
ident
addit
synonym
mutat
sequenc
c
protein
gene
g
contain
singl
nonsynonym
mutat
u
strikingli
untransl
region
utr
contain
delet
nt
cgaucgagug
locat
nt
upstream
genom
end
present
isol
thu
far
sequenc
present
genbank
april
ng
read
cover
posit
notic
mutat
encod
gln
substitut
near
socal
cleavag
site
viral
protein
see
discuss
read
wildtyp
sequenc
ratio
approxim
observ
ratio
larg
small
plaqu
perform
plaqu
assay
viru
stock
fig
leftmost
well
pick
multipl
plaqu
size
passag
three
time
vero
cell
monitor
plaqu
phenotyp
interestingli
sever
smallplaqu
viru
clone
like
fig
observ
rapid
convers
mix
largeplaqu
phenotyp
three
passag
largeplaqu
viru
clone
like
stabli
retain
plaqu
phenotyp
fig
ng
analysi
genom
largeplaqu
viru
reveal
read
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
cleavag
site
region
contain
mutat
describ
mutat
detect
genom
thu
clearli
link
gln
substitut
protein
largeplaqu
phenotyp
observ
viru
next
also
analys
genom
virus
deriv
smallplaqu
pick
viru
clone
retain
smallplaqu
phenotyp
first
passag
fig
began
yield
increas
proport
larg
r
plaqu
subsequ
passag
sequenc
fig
reveal
varieti
lowfrequ
read
mutat
near
cleavag
site
motif
aa
specifi
gln
substitut
domin
one
read
cover
nt
genom
lower
frequenc
singlenucleotid
chang
specifi
trp
leu
substitut
also
detect
furthermor
delet
residu
eras
cleavag
site
region
discov
well
delet
residu
immedi
preced
region
amount
larg
plaqu
increas
substanti
upon
next
passag
ng
reveal
promin
emerg
mutant
contain
delet
gln
point
mutat
read
respect
yet
minor
variant
mutat
sequenc
discov
taken
togeth
data
clearli
link
largeplaqu
phenotyp
acquisit
mutat
particular
region
protein
appar
provid
strong
select
advantag
passag
vero
cell
knowledg
detail
comparison
sarscov
replic
kinet
cell
cultur
report
far
therefor
infect
vero
cell
viru
stock
high
moi
analys
viral
rna
synthesi
protein
express
releas
infecti
viral
progeni
fig
experi
perform
use
also
monitor
viral
protein
product
western
blot
analysi
use
antisera
target
nonstructur
structur
n
protein
expect
rna
analysi
accumul
viral
protein
increas
time
detect
somewhat
earlier
sarscov
data
shown
overal
conclud
vero
cell
produc
level
intracellular
rna
protein
least
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
compar
sarscov
although
translat
releas
equal
amount
infecti
viral
progeni
fig
abl
follow
viru
replic
cell
close
explor
crossreact
varieti
antisera
previous
rais
sarscov
target
particular
varieti
nsp
earlier
studi
mani
found
crossreact
also
correspond
merscov
target
despit
rel
larg
evolutionari
distanc
merscov
sarscov
base
much
closer
relationship
similar
better
crossreact
sarscov
reagent
expect
explor
use
immunofluoresc
microscopi
inde
antisera
recogn
sarscov
nsp
test
strongli
crossreact
correspond
target
fig
tabl
except
polyclon
rabbit
antiserum
likewis
polyclon
rabbit
antiserum
mous
monoclon
antibodi
recogn
n
protein
react
strongli
fig
tabl
true
rabbit
antiserum
rais
ctermin
peptid
sarscov
protein
fig
label
pattern
essenti
elabor
membran
structur
viral
ro
form
fig
c
punctat
structur
area
cell
label
use
antibodi
recogn
strand
rna
dsrna
presum
recogn
replic
intermedi
viral
rna
synthesi
n
protein
signal
diffus
cytosol
fig
wherea
protein
label
predominantli
show
expect
local
golgi
complex
fig
next
use
electron
microscopi
investig
ultrastructur
chang
induc
infect
cell
focus
membran
replic
organel
ro
support
viral
rna
synthesi
assembl
releas
new
virion
fig
compar
mockinfect
control
cell
fig
variou
distinct
membran
alter
observ
cell
infect
either
sarscov
fig
h
pi
larger
region
membran
alter
found
particularli
cell
infect
data
shown
may
align
somewhat
faster
onset
intracellular
rna
synthesi
vero
cell
fig
asterisk
addit
convolut
membran
readili
detect
covinfect
cell
zipper
er
appear
predomin
structur
cell
fig
white
arrowhead
previous
describ
sarscov
also
dmv
appear
fuse
outer
membran
give
rise
vesicl
packet
increas
number
infect
progress
fig
white
asterisk
viru
bud
near
golgi
apparatu
presum
smooth
membran
ergolgi
intermedi
compart
ergic
frequent
observ
h
pi
fig
step
follow
transport
plasma
membran
releas
viru
particl
extracellular
space
h
pi
releas
progeni
virion
abundantli
detect
around
infect
cell
fig
contribut
lower
progeni
titr
obtain
viru
fig
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
order
establish
valid
cpebas
assay
identifi
potenti
inhibitor
replic
select
four
previous
identifi
inhibitor
cov
replic
remdesivir
chloroquin
alisporivir
pegyl
interferon
alpha
cell
infect
low
moi
allow
multipl
cycl
replic
three
day
colorimetr
cell
viabil
assay
virus
si
fig
alisporivir
known
inhibitor
differ
group
rna
virus
previous
found
effect
reduc
product
cov
progeni
studi
measur
valu
sarscov
respect
fig
si
treatment
complet
inhibit
replic
even
lowest
dose
ngml
fig
line
previou
result
sarscov
much
less
sensit
treatment
yield
partial
inhibit
concentr
test
ngml
overal
conclud
vero
cell
provid
suitabl
basi
perform
antivir
compound
screen
select
promis
hit
indepth
mechanist
studi
develop
report
describ
compar
analysi
replic
featur
sarscov
vero
cell
one
commonli
use
cell
line
studi
two
virus
howev
contrast
stabl
phenotyp
exhibit
sarscov
year
work
viru
cell
began
exhibit
remark
phenotyp
variat
plaqu
assay
within
passag
isol
clinic
sampl
fig
addit
isol
use
studi
nucleotid
substitut
protein
gene
clearli
establish
singl
protein
mutat
gln
respons
observ
plaqu
size
differ
mutat
local
near
socal
furinlik
cleavag
site
fig
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
fig
variant
contain
either
singl
point
mutat
delet
aa
fig
resembl
variant
recent
report
laboratori
interestingli
similar
chang
also
observ
clinic
isol
passag
cell
cultur
current
investig
mutat
inactiv
furinlik
cleavag
site
provid
major
select
advantag
passag
vero
cell
translat
strike
largeplaqu
phenotyp
document
paper
addit
remark
featur
confirm
resequenc
isol
presenc
delet
utr
genom
screen
avail
genom
sequenc
indic
presenc
delet
appar
uniqu
particular
isol
like
repres
addit
adapt
acquir
cell
cultur
passag
delet
map
previous
describ
hypervari
region
otherwis
conserv
utr
particular
socal
motif
conserv
among
cov
also
found
sever
viru
group
element
implic
bind
host
factor
viral
rna
exact
function
remain
enigmat
thu
far
strikingli
mous
hepat
coronaviru
entir
hypervari
region
includ
found
dispens
replic
cell
cultur
highli
relev
viral
pathogenesi
mice
although
impact
delet
remain
studi
detail
previou
data
suggest
mutat
need
major
impact
replic
vero
cell
notion
also
support
fact
result
antivir
screen
assay
fig
correl
well
similar
studi
perform
isol
clearli
could
differ
vivo
studi
would
probabl
better
reli
isol
carri
delet
vero
cell
commonli
use
isol
propag
studi
sarscovlik
virus
support
viral
replic
high
titr
may
due
high
express
level
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
receptor
use
sarscov
andor
fact
lack
abil
produc
interferon
interest
evalu
whether
similarli
strong
select
pressur
adapt
region
protein
passag
cell
type
studi
current
progress
laboratori
alreadi
establish
cell
may
poor
choic
despit
fact
use
viru
propag
antivir
screen
studi
immunolabel
infect
cell
data
shown
reveal
nonproduct
infect
small
fraction
cell
gener
lack
cytopatholog
cell
line
evalu
illustr
monitor
plaqu
phenotyp
plaqu
size
homogen
may
provid
quick
conveni
method
assess
composit
stock
propag
vero
cell
least
concern
evolut
region
protein
given
ongo
pandem
detail
character
replic
cycl
import
step
understand
molecular
biolog
viru
defin
potenti
target
inhibitor
replic
crossreact
antisera
describ
studi
tabl
use
tool
studi
gener
subcellular
local
viral
nsp
structur
protein
fig
ultrastructur
chang
associ
ro
format
fig
similar
two
virus
also
observ
compar
replic
kinet
sarscov
vero
cell
although
clearli
lower
final
infect
titr
measur
lower
fig
nevertheless
rna
synthesi
could
detect
somewhat
earlier
overal
amount
viral
rna
produc
exceed
produc
sarscov
fig
may
indic
certain
assembl
matur
problem
virushost
interact
differ
case
possibl
merit
investig
particular
sinc
preliminari
em
studi
suggest
intrigu
differ
sarscov
concern
presenc
spike
surfac
freshli
releas
particl
fig
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
analysi
subgenom
mrna
synthesi
reveal
increas
rel
abund
mrna
respect
compar
sarscov
mechanist
differ
appear
caus
extend
base
pair
possibl
transcript
regulatori
sequenc
direct
synthesi
two
mrna
sarscov
encod
two
protein
protein
latter
presum
express
follow
leaki
ribosom
scan
upon
ectop
express
protein
report
induc
apoptosi
via
caspasedepend
pathway
andor
involv
cell
cycl
arrest
product
poorli
studi
integr
membran
protein
also
detect
virion
delet
sarscov
genom
minim
impact
kinet
viru
replic
vitro
differ
cell
line
includ
vero
cell
vivo
use
mice
anoth
studi
howev
partial
delet
sarscov
report
provid
replic
advantag
cell
vero
cell
sarscov
protein
membraneassoci
abl
induc
endoplasm
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
may
thu
relev
understand
wide
spectrum
respiratori
diseas
symptom
observ
patient
base
close
ancestr
relationship
sarscov
one
might
expect
pattern
mode
interact
host
antivir
defenc
mechan
would
similar
howev
experi
type
interferon
treatment
vero
cell
fig
reveal
clear
differ
consider
sensit
sarscov
also
observ
laboratori
essenti
replic
could
inhibit
similarli
low
concentr
inhibit
merscov
replic
cell
cultur
taken
togeth
data
suggest
less
abl
counter
prime
type
ifn
respons
sarscov
previous
identifi
inhibitor
cov
replic
use
valid
cellbas
assay
inhibitor
screen
compound
inhibit
replic
similar
lowmicromolar
concentr
similar
dosedepend
manner
observ
sarscov
fig
remdesivir
prodrug
adenosin
analogu
develop
gilead
scienc
demonstr
target
cov
rna
polymeras
act
chain
termin
clinic
efficaci
remdesivir
still
evalu
first
encourag
result
worldwid
compassion
use
trial
conduct
likewis
hydroxychloroquin
chloroquin
label
potenti
game
changer
evalu
treatment
sever
patient
compound
use
treat
malaria
amebiasi
drugresist
plasmodium
strain
emerg
compound
incorpor
endosom
lysosom
rais
ph
insid
intracellular
compart
turn
may
lead
defect
protein
degrad
intracellular
traffick
altern
hypothesi
explain
antisarscov
activ
base
impact
glycosyl
receptor
use
sarscov
final
expect
immunosuppress
cyclosporin
analogu
alisporivir
inhibit
replic
demonstr
previous
sarscov
merscov
although
exact
mode
show
remark
plaqu
heterogen
vero
cell
leftmost
well
follow
plaqu
assay
viru
stock
small
larg
plaqu
pick
viru
clone
passag
three
time
vero
cell
plaqu
phenotyp
monitor
contrast
larg
plaqu
virus
exampl
bottom
row
plaqu
phenotyp
small
plaqu
virus
exampl
top
row
rapidli
evolv
within
passag
b
evolutionadapt
protein
gene
vero
passag
overview
ng
data
obtain
stock
region
protein
gene
encod
socal
furinlik
cleavag
site
analysi
vero
cell
separ
agaros
gel
probe
radiolabel
oligonucleotid
recogn
genom
subgenom
mrna
virus
subsequ
gel
rehybrid
probe
specif
ribosom
rna
use
load
control
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
tabl
sarscovspecif
antisera
use
crossreact
correspond
target
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
